People with chronic obstructive pulmonary disease (COPD) and arthritis have a higher risk of death than people with arthritis who do not have COPD, according to a new study.
UK MHRA approves AbbVie’s migraine prevention drug Aquipta
Phase III data showed that AbbVie’s Aquipta offered a substantial decline in mean monthly migraine days from baseline to 12 weeks. Credit: baranq/Shutterstock.com. The UK